These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin. Pong A, Thomson KS, Moland ES, Chartrand SA, Sanders CC. J Antimicrob Chemother; 1999 Nov; 44(5):621-7. PubMed ID: 10552978 [Abstract] [Full Text] [Related]
13. In vitro activity of PD127,391, a new quinolone against bacterial isolates from cancer patients. Rolston KV, Ho DH, LeBlanc B, Bodey GP. Chemotherapy; 1990 Nov; 36(5):365-72. PubMed ID: 2209169 [Abstract] [Full Text] [Related]
19. In vitro activity of fleroxacin against multiresistant gram-negative bacilli isolated from patients with nosocomial infections. Araque M, Velazco E. Intensive Care Med; 1998 Aug; 24(8):839-44. PubMed ID: 9757930 [Abstract] [Full Text] [Related]
20. Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998. Huczko E, Conetta B, Bonner D, Valera L, Stickle T, Macko A, Fung-Tomc J. Int J Antimicrob Agents; 2000 Dec; 16(4):401-5. PubMed ID: 11118848 [Abstract] [Full Text] [Related] Page: [Next] [New Search]